Literature DB >> 16393781

The extraordinary ligand binding properties of human serum albumin.

Mauro Fasano1, Stephen Curry, Enzo Terreno, Monica Galliano, Gabriella Fanali, Pasquale Narciso, Stefania Notari, Paolo Ascenzi.   

Abstract

Human serum albumin (HSA), the most prominent protein in plasma, binds different classes of ligands at multiple sites. HSA provides a depot for many compounds, affects pharmacokinetics of many drugs, holds some ligands in a strained orientation providing their metabolic modification, renders potential toxins harmless transporting them to disposal sites, accounts for most of the antioxidant capacity of human serum, and acts as a NO-carrier. The globular domain structural organization of monomeric HSA is at the root of its allosteric properties which are reminiscent of those of multimeric proteins. Here, structural, functional, biotechnological, and biomedical aspects of ligand binding to HSA are summarized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16393781     DOI: 10.1080/15216540500404093

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  178 in total

1.  Heparin-Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed Intestine.

Authors:  Sufeng Zhang; Won Joon Cho; Amy T Jin; Lie Yun Kok; Yunhua Shi; David E Heller; Young-Ah Lucy Lee; Yixuan Zhou; Xi Xie; Joshua R Korzenik; Jochen K Lennerz; Giovanni Traverso
Journal:  Adv Healthc Mater       Date:  2020-06-29       Impact factor: 9.933

2.  The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan.

Authors:  K S Joseph; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2010-05-06       Impact factor: 3.935

3.  Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography.

Authors:  K S Joseph; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-06-01       Impact factor: 3.205

4.  Albumin Inhibits Pseudomonas aeruginosa Quorum Sensing and Alters Polymicrobial Interactions.

Authors:  Allie Clinton Smith; Anne Rice; Bryan Sutton; Rebecca Gabrilska; Aimee K Wessel; Marvin Whiteley; Kendra P Rumbaugh
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

5.  Recent advances in nanoengineering cellulose for cargo delivery.

Authors:  Amir Sheikhi; Joel Hayashi; James Eichenbaum; Mark Gutin; Nicole Kuntjoro; Danial Khorsandi; Ali Khademhosseini
Journal:  J Control Release       Date:  2018-11-27       Impact factor: 9.776

Review 6.  Are clinical findings of systemic titanium dispersion following implantation explained by available in vitro evidence? An evidence-based analysis.

Authors:  Justin Paul Curtin; Minji Wang
Journal:  J Biol Inorg Chem       Date:  2017-05-17       Impact factor: 3.358

7.  Interaction of Sulfadiazine with Model Water Soluble Proteins: A Combined Fluorescence Spectroscopic and Molecular Modeling Approach.

Authors:  Mullah Muhaiminul Islam; N Shaemningwar Moyon; Pynsakhiat Miki Gashnga; Sivaprasad Mitra
Journal:  J Fluoresc       Date:  2013-11-28       Impact factor: 2.217

8.  Exploring titanium(IV) chemical proximity to iron(III) to elucidate a function for Ti(IV) in the human body.

Authors:  Manoj Saxena; Sergio A Loza-Rosas; Kavita Gaur; Shweta Sharma; Sofia C Pérez Otero; Arthur D Tinoco
Journal:  Coord Chem Rev       Date:  2018-03-20       Impact factor: 22.315

Review 9.  Protein engineering: a new frontier for biological therapeutics.

Authors:  Peter H Tobin; David H Richards; Randolph A Callender; Corey J Wilson
Journal:  Curr Drug Metab       Date:  2014       Impact factor: 3.731

10.  Assessment of albumin removal from an immunoaffinity spin column: critical implications for proteomic examination of the albuminome and albumin-depleted samples.

Authors:  Rebekah L Gundry; Melanie Y White; Julie Nogee; Irina Tchernyshyov; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2009-04       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.